Hadji, P; Blettner, M; Harbeck, N et al.
Non-Compliance in der adjuvanten endokrinen Therapie des MammakarzinomsFrauenarzt. Bd. 48. 2007 S. 249-252
Fineschi, M; Gori, T; Pierli, C et al.
Non-Q-wave myocardial infarction associated with three-vessel thrombosis.J Cardiovasc Med (Hagerstown). Bd. 8. H. 6. 2007 S. 457-8
Buhl, A; Metzger, JH; Heegaard, NH et al.
Novel Biosensor-Based Analytic Device for the Detection of Anti-Double-Stranded DNA Antibodies.Clin Chem. Bd. 53. 2007 S. 334-341
Wenzel, JJ; Rossmann, H; Lackner, KJ et al.
Novel human pathological mutations. Gene symbol: MEN1. Disease: MEN1, Multiple endocrine neoplasia, type 1.Hum Genet. Bd. 122. H. 3-4. 2007 S. 416
Dittmar, M; Bischofs, C; Kanitz, M et al.
Novel mutations in the DNase gene are associated with decreased DNase activity in thyroid autoimmunityAnnual Meeting of the American Thyroid Association, New York City, October 2007Thyroid. Bd. 17. H. sup1. 2007 S. pp79
Hadaschik, B; Sowery, RD; Gleave, ME
Novel targets and approaches in advanced prostate cancerCurr Opin Urol. Bd. 17. 2007 S. 182-187
Gockel, I; Schimanski, CC; Moehler, M et al.
Novel therapeutic targets in esophageal cancer: impact of chemokine receptor CXCR4.Future Oncol. Bd. 3. H. 2. 2007 S. 119-22
Stauber, RH; Mann, W; Knauer, SK
Nuclear and Cytoplasmic Survivin: Molecular Mechanism, Prognostic, and Therapeutic Potential.Cancer Res. Bd. 67. H. 13. 2007 S. 5579-82
Knauer, SK; Kramer, OH; Knosel, T et al.
Nuclear export is essential for the tumor-promoting activity of survivin.FASEB J. Bd. 21. H. 1. 2007 S. 207-16
von Landenberg, P; Bauer, S
Nucleic acid recognizing Toll-like receptors and autoimmunity.Curr Opin Immunol. Bd. 19. H. 6. 2007 S. 606-10